首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pharmacopsychiatry

缩写:PHARMACOPSYCHIATRY

ISSN:0176-3679

e-ISSN:1439-0795

IF/分区:2.2/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引779
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Scott Monteith,Tasha Glenn,John R Geddes et al. Scott Monteith et al.
Both patients and physicians are routinely exposed to the corporate promotion of artificial intelligence (AI) for healthcare products. Hype for AI products may impact both patient behavior and attitudes about healthcare. Corporate AI hype m...
Damian Swieczkowski,Aleksander Kwaśny,Michal Pruc et al. Damian Swieczkowski et al.
Regulatory compliance is crucial in the clinical development of psychedelic substances, including psilocybin. This study aimed to examine the alignment of clinical trial protocols for psilocybin in the treatment of major depressive disorder...
Nazar Kuzo,Marianna Piras,Ulrich C Lutz et al. Nazar Kuzo et al.
Clozapine is a recommended treatment for psychotic symptoms in patients with Parkinson's disease (PD) and/or dementia. However, the therapeutic reference range for clozapine in these patients has not been established hitherto.The study was ...
Tingting Liu,Fuqiang Shi,Zhihua Guo et al. Tingting Liu et al.
Alcohol use disorder (AUD) is a prevalent neuropsychiatric disorder with serious health and social consequences. However, few licensed and successful pharmacotherapies exist for heterogeneous and complex disorders such as AUD, and these are...
Emytis Tavakoli,Angela Xiang,Mohamed I Husain et al. Emytis Tavakoli et al.
Measurement-based care (MBC) involves systematically assessing patients' symptoms and adverse events using standardized scales to guide treatment. While MBC has been shown to enhance the quality of care and outcomes in the pharmacotherapy o...
Sota Tomiyama,Kazunari Yoshida,Hideaki Tani et al. Sota Tomiyama et al.
Currently available systematic reviews on the pharmacological treatment of autism spectrum disorder (ASD) do not encompass all the evidence, as they exclude guidelines issued by national or local authorities that are not indexed in search e...
Taro Kishi,Leslie Citrome,Kenji Sakuma et al. Taro Kishi et al.
The United States Food and Drug Administration approved the xanomeline-trospium combination in September 2024 for treating schizophrenia, based in part on three double-blind, randomized placebo-controlled trials in adults with schizophrenia...
Fabian Sattaf,Maike Scherf-Clavel,Stefan Unterecker et al. Fabian Sattaf et al.
Dose-related reference ranges can be used in therapeutic drug monitoring to monitor pharmacotherapy. The deviation of a measured serum concentration from the expected serum concentration at the corresponding dose can thus be identified earl...
Marcus Ising,Florian Holsboer,Marius Myhsok et al. Marcus Ising et al.
A subgroup of patients with acute depression show an impaired regulation of the hypothalamic-pituitary-adrenocortical axis, which can be sensitively diagnosed with the combined dexamethasone (dex)/corticotropin releasing hormone (CRH)-test....